Borrelia burgdorferi

2 articles
Lyme Disease Vaccine Candidate VLA15 Advances Through Phase 1 Trials
Jul 16, 2018 | Emily Wolfson

  Valneva, a French biotech company focused on developing vaccines, has announced it has obtained successful Phase 1 results for its Lyme disease...

Lyme Disease Cases Triple in the US
Jul 14, 2017 | Kristy Leker

  Lyme disease has been strongly concentrated in the North American Midwest and Northeastern regions, where ticks and contact with ticks are common....